Dermaheal Eyebag Solution (5 vials x 1,5 ml)

The solution works through four targeted peptides: Tripeptide-41 (CG-Lipoxyn) stimulates fat burning, Nonapeptide-18 (CG-Formade) prevents new fat accumulation, and Oligopeptides 61 and 73 improve skin tone and microcirculation. This biological lipolysis is a non-aggressive alternative to traditional fat dissolvers, focusing on the specific anatomical needs of the thin periorbital skin.

Strictly contraindicated. No clinical safety data exists for peptide-based lipolytic solutions during pregnancy. We defer all elective aesthetic treatments until after the breastfeeding period has completely concluded to maintain the highest clinical standards.

The formulation contains Tripeptide-41 (CG-Lipoxyn), Nonapeptide-18 (CG-Formade), Oligopeptide-61 (CG-Cellin), and Oligopeptide-73 (CG-EPG).

The standard treatment protocol involves one session per week for a total of 4 sessions. Typically, 0.75 ml to 1.5 ml (half to one vial) is sufficient to treat both lower eyelids. Practitioners should evaluate if targeted micro-dosing is appropriate for minor seasonal puffiness. For maintenance, a single session every 3 months is recommended to prevent new adipose accumulation. For global skin quality improvement, Fillmed NCTF 135 HA can be integrated into the wider face protocol.

Common reactions include temporary redness, localized edema (swelling), and potential purple bruising at the injection sites. These effects are generally mild and resolve within 2 to 4 days. Patients should strictly follow our expert aftercare guide to ensure optimal drainage. Any persistent inflammatory nodules should be immediately reported to the treating professional.

Avoid alcohol for 24h before and 48h after the procedure. Alcohol consumption leads to significant fluid retention and vasodilation, which can directly counteract the drainage effects of the Eyebag Solution and increase post-procedural swelling.